EORTC Membership Committee (MC)

The Membership Committee (MC) was created and approved by the Board in November 2004. Since then, EORTC membership eligibility is subject to a ‘location criterion’ restricting membership to ‘geographical Europe’. More specifically, the geographical scope of participation is limited to centres located in Europe. However, centres from the Mediterranean countries (i.e. Turkey, Israel and Egypt) which have been members of the EORTC before the ‘location criterion’ was introduced may continue as members of the EORTC. However, institutions located outside ‘geographical Europe’ which are not members of the EORTC are invited to collaborate in so-called ‘EORTC Intergroup studies’.


Intergroup studies are decided upon on a case by case basis, according to the abilities of the potential collaborating groups, i.e. whether these groups contribute sufficiently to the study by contributing a large number of centres with a significant number of patients.


Members


Chairman: A.T. van Oosterom, Leuven (BE)
Secretary: A. Marinus, EORTC Headquarters Brussels (BE)


T. Conroy, Vandoeuvre les Nancy (FR)
T. de Witte, Nijmegen (NL)
J.W. Leer, Nijmegen (NL)
F. Meunier, EORTC, Director General, Brussels (BE)
R. Mirimanoff, Lausanne (CH)


Each year, any institution / member entering 15 or less patients into EORTC clinical trials over the previous 3 years, will be officially notified that their membership is at risk of being withdrawn unless there is an increase in the level of activities of the institution / member over the following year.


New membership to the EORTC has been reorganised in a centralised procedure:
Any new applicant (institution/member) must submit a membership application to the Membership Committee. In the decision-making process, the Membership Committee assesses the application in question according to the following criteria:
• track research record of the institution/member
• status of available medical facilities of the institution/member
• availability of qualified personnel for clinical trial management of the institution/member
• the potential benefit for other EORTC institutions/members the applying institution/member might provide.


Lastly, the Board grants membership on the basis of a report issued by the Membership Committee in collaboration with the EORTC Chairmen of the relevant EORTC Groups.


For further information regarding membership, please contact the EORTC Membership Committee
at the following address: Avenue Mounier 83/11, B-1200 Brussels
E-mail: membership[at]eortc.be